Impossible Foods

Market position

The company described itself in November 2021 as the fastest-growing plant-based meat company in U.S. retail, citing custom IRI research covering a 13-week period versus the prior year and stating it outpaced the next ten leading plant-based meat companies combined. Its main rival is publicly listed Beyond Meat, whose revenues and retail demand were reported to be weakening at that time. The broader plant-based meat sector has faced headwinds since the 2019-2021 peak, and in 2024 the CEO acknowledged the category "is not where it needs to be."

Unlike most plant-based meat products, Impossible's products contain heme, produced from soy leghemoglobin via genetically engineered yeast and fermentation, which the company credits for meat-like flavor. The company also emphasizes nutrition claims (19 g protein and 0 mg cholesterol per 4 oz serving of Impossible Beef, 33% less fat and 6 g versus 9 g saturated fat compared with USDA 80/20 animal ground beef, 25% daily value of iron) and environmental claims (approximately 96% less land, 92% less water and 91% fewer greenhouse gases than animal beef, per the company site; Wikipedia cites earlier company figures of 95% less land, 74% less water and about 87% less greenhouse gas). The 2024 Motif settlement and acquisition strengthened its heme intellectual property position.

Technology

The company's core technology is heme, specifically the leghemoglobin molecule found naturally in the roots of soy plants, which it produces at scale by genetically engineering a yeast and using a fermentation process similar to brewing. The plant-derived heme molecule is described as identical to the heme found in meat and provides the meaty flavor. Impossible Beef combines soy protein, heme, sunflower and coconut oils for fat, and binders. The 2024 acquisition of Motif FoodWorks' heme-related business added access to HEMAMI (animal-free bovine myoglobin) and related expertise, complementing the company's soy leghemoglobin platform.

Go-to-market

Impossible Foods entered the market through chef- and restaurant-led launches (Momofuku Nishi, Jardinière, Cockscomb, Crossroads Kitchen, Public), then scaled via multi-unit and national quick-service chains including Bareburger, Umami Burger, Hopdoddy, White Castle, Burger King, Little Caesars and Jack in the Box, before adding grocery retail distribution starting in 2019. It also pursues co-branded collaborations and venue partnerships, such as branded marketplaces at Climate Pledge Arena where Impossible Burger was named the official burger of the NHL's Seattle Kraken. A 2024 marketing campaign created with the agency Erich and Kallman used the tagline "solve the meat problem with more meat."

Retail grocery shoppers and restaurant/foodservice diners. Following a 2024 repositioning, marketing explicitly targets meat-eaters and the roughly 100 million U.S. flexitarians, emphasizing taste and craveability rather than environmental messaging. Certain products also target family/kids segments (Disney-licensed nuggets, Wild Nuggies) and health-oriented buyers (Lite Beef, endorsed by the American Diabetes Association's Better Choices for Life Program).

Geography

Headquartered in Redwood City, California, with early production in Redwood City and at Rutgers University in New Jersey and a large-scale plant announced in Oakland, California, in 2017. Distribution spans the United States, Canada, Australia, New Zealand, Hong Kong, Singapore, the United Arab Emirates and the United Kingdom. Four new international markets were added in the 14 months preceding November 2021, including Canada, the UAE, and Australia and New Zealand. European market entry has been delayed by regulatory hurdles, though EFSA has declared the company's fermented soy leghemoglobin safe for consumption.

History

Founded in 2011 as a stealth R&D startup, the company declared soy leghemoglobin generally recognized as safe in 2014 following FDA-overseen testing. It launched the Impossible Burger in July 2016, first served at Momofuku Nishi in New York, and produced early volumes in Redwood City, California, and at Rutgers University in New Jersey. In March 2017 it announced its first large-scale plant in Oakland, California, targeting one million pounds of plant-based meat per month. White Castle began serving Impossible Burgers in April 2018, eventually across all 377 locations; by July 2018 the product was in roughly 3,000 U.S. and Hong Kong locations and by end-2018 in 5,000 restaurants across all 50 states. Impossible Burger 2.0 launched in January 2019, Little Caesars introduced the company's first plant-based sausage in May 2019, and Burger King rolled out the Impossible Whopper nationwide in August 2019. Retail sales began in October 2019 at Gelson's, expanding to Fairway, Wegmans, Jewel-Osco, Vons, Pavilions, Albertsons, Safeway and Kroger banners by May 2020. Impossible Sausage/Pork launched more widely in January 2020 and Impossible Chicken in late 2021. Restructurings followed in October 2022 (about 6% of staff) and reportedly about 20% in early 2023; in September 2024 the company acquired Motif FoodWorks' heme-related business as part of a patent litigation settlement and executed a broad rebrand.

Risks & controversies

The plant-based meat category has contracted since its 2019-2021 peak, and the company remains unprofitable, having cut roughly 6% of staff in October 2022 and a reported 20% in early 2023. Its heme ingredient has faced repeated regulatory scrutiny: FDA GRAS filings and updates in 2014, 2017 and 2018, a 2018 "no questions" letter limited to restaurant-cooked burgers, colorant approval for uncooked products in July 2019, an objection resolved in December 2019, and a challenge dismissed by a San Francisco federal appeals court in May 2021, which held the FDA had substantial evidence to deem the heme safe. Soy leghemoglobin appears on Whole Foods' banned ingredient list, excluding Impossible's beef products from that retailer, and European launch has been delayed by regulatory hurdles. Leadership turnover includes founder Patrick Brown's 2022 departure from the CEO role.